These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21134406)

  • 1. Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery.
    Di Maio S; Carrier RL
    J Control Release; 2011 Apr; 151(2):110-22. PubMed ID: 21134406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
    Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
    Koziolek M; Garbacz G; Neumann M; Weitschies W
    Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
    Shono Y; Jantratid E; Dressman JB
    Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form.
    Souliman S; Blanquet S; Beyssac E; Cardot JM
    Eur J Pharm Sci; 2006 Jan; 27(1):72-9. PubMed ID: 16169713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.
    Chakraborty S; Shukla D; Mishra B; Singh S
    Eur J Pharm Biopharm; 2009 Sep; 73(1):1-15. PubMed ID: 19505572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
    Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
    Rubbens J; Brouwers J; Tack J; Augustijns P
    Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
    Porter CJ; Pouton CW; Cuine JF; Charman WN
    Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of lipid digestibility using structured emulsion-based delivery systems: comparison of in vivo and in vitro measurements.
    Li Y; Kim J; Park Y; McClements DJ
    Food Funct; 2012 May; 3(5):528-36. PubMed ID: 22344205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
    Porter CJ; Trevaskis NL; Charman WN
    Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.
    Charman WN; Porter CJ; Mithani S; Dressman JB
    J Pharm Sci; 1997 Mar; 86(3):269-82. PubMed ID: 9050793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models for predicting drug absorption and metabolism.
    Alqahtani S; Mohamed LA; Kaddoumi A
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1241-54. PubMed ID: 23687990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biopharmaceutical considerations of dissolution testing used as a prognostic tool for oral drug adsorption].
    Antal I
    Acta Pharm Hung; 2001 Oct; 71(3):280-8. PubMed ID: 11961894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption.
    del Amo EM; Heikkinen AT; Mönkkönen J
    Eur J Pharm Sci; 2009 Feb; 36(2-3):200-11. PubMed ID: 19063964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants).
    Kamstrup D; Berthelsen R; Sassene PJ; Selen A; Müllertz A
    AAPS PharmSciTech; 2017 Feb; 18(2):317-329. PubMed ID: 27796909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
    Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life.
    Arnold YE; Imanidis G; Kuentz M
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1262-9. PubMed ID: 22206451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.